Table 1.
Contribution of transplanted BM in the small intestine.
Donor | Genotype | Epithelial | CD45+ cells | CD105+ cells | α-SMA+ cells |
---|---|---|---|---|---|
Fraction of GFP + cells in villi | |||||
Whole BM | WT | 1.5% | 86.7% | 80.2% | 4.0% |
PUMA KO | 4.0% | 79.6% | 83.4% | 3.8% | |
CD45+ BM | WT | 1.8% | 85.7% | 89.8% | 4.5% |
PUMA KO | 2.9% | 76.6% | 87.6% | 8.5% | |
Fraction of GFP + cells in crypts | |||||
Whole BM | WT | 2.9% | 95.5% | 74.2% | 3.8% |
PUMA KO | 1.7% | 91.1% | 76.5% | 2.0% | |
CD45+ BM | WT | 0.0% | 88.5% | 83.8% | 0.0% |
PUMA KO | 0.0% | 83.8% | 87.5% | 0.0% |
α-SMA, α-smooth muscle actin; BM, bone marrow; GFP, green fluorescent protein; WT, wild type.
Intestinal sections were double stained with a lineage-specific marker and GFP. GFP + donor cells were then counted within each cell compartment, and recorded as a percentage of the total cells within each specific lineage. At least 100 crypt-villus structures were counted for each determination, n = 3 mice per group.